News
Media
Conference
Publications
Resources
Partners
Subscribe

Spotlight -

Geographic Atrophy

Fred Gebhart

Articles by Fred Gebhart

Adalimumab therapy safe, effective in real-world, open-label uveitis study

ByFred Gebhart,Eric B. Suhler, MD, MPH

May 1st 2018

Latest Updated Articles

Adalimumab therapy safe, effective in real-world, open-label uveitis study
Published: May 1st 2018 | Updated:

Trending on Modern Retina

Belite Bio announces NDA acceptance of tinlarbant by China’s NMPA

Retina roundup: October 20 to October 24

© 2025 MJH Life Sciences^®

All rights reserved.